Eli Lilly oncology unit gets USFDA nod for Jaypirca to treat mantle cell lymphoma Ruchika Sharma29 Jan 2023 10:45 AM GMTMCL is a rare blood cancer and a form of non-Hodgkin lymphoma.
Eli Lilly gets CDCSO panel nod to import, market Galcanezumab Medical Dialogues Team25 Jan 2023 12:14 PM GMTNew Delhi: Drug major, Eli Lilly has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
USFDA accepts supplemental New Drug Application for Jardiance for adults with chronic kidney disease: Eli Lilly Ruchika Sharma22 Jan 2023 6:30 AM GMTIndianapolis: The U.S. Food and Drug Administration (USFDA) has accepted a supplemental New Drug Application (sNDA) for Jardiance (empagliflozin)...
USFDA rejects accelerated approval for Eli Lilly Alzheimer's drug Donanemab Ruchika Sharma20 Jan 2023 8:00 AM GMT"I don't think it says anything negative about the drug. It was just a manifestation of the study design," said Dr. Ronald Petersen, an Alzheimer's...
Eli Lilly, AbbVie exit UK drug pricing agreement Ruchika Sharma17 Jan 2023 9:00 AM GMTBengaluru: Pharmaceutical companies AbbVie and Eli Lilly have withdrawn from Britain's voluntary medicines pricing agreement, an industry body said on...
Eli Lilly, PeptiDream ink pact for discovery of novel Peptide Drug Conjugates Ruchika Sharma29 Dec 2022 6:45 AM GMTUnder the terms of the agreement, PeptiDream will receive an upfront payment from Lilly as well as be eligible for payments based on the achievement...
USFDA adds Eli Lilly diabetes drug Mounjaro to list of drugs facing shortages Ruchika Sharma18 Dec 2022 8:30 AM GMTThe company is expanding its manufacturing capacity for the two drugs through its facility in North Carolina, and doubling it by the end of 2023.
Eli Lilly, EVA Pharma collaborate to provide affordable insulin to diabetic patients in Africa Ruchika Sharma15 Dec 2022 5:30 AM GMTIndianapolis: Eli Lilly and Company and EVA Pharma have announced a collaboration to deliver a sustainable supply of high-quality,...
Eli Lilly hopes to launch as many as 5 new treatments next year Ruchika Sharma14 Dec 2022 9:45 AM GMTIndianapolis: Eli Lilly and Co said on Tuesday it hopes to launch as many as five new treatments next year that could drive growth through the decade...
Eli Lilly concludes acquisition of Akouos Ruchika Sharma5 Dec 2022 6:00 AM GMTIndianapolis: Eli Lilly and Company has recently announced the successful completion of its acquisition of Akouos, Inc. "The acquisition...
COVID-19 Treatment : Eli Lilly's Bebtelovimab no longer authorized by USFDA Ruchika Sharma1 Dec 2022 10:00 AM GMTEli Lilly and its authorized distributors have paused the commercial distribution of the monoclonal antibody until further notice from the agency.
Eli Lilly unveils DCGI approved Ramiven in India for early stage breast cancer Ruchika Sharma24 Nov 2022 10:30 AM GMTRamiven (abemaciclib) is a targeted treatment known as a CDK4/6 inhibitor.
